Purchase Order 75D30120P09399
Award Date 8/17/20
Potential Completion Date 8/16/23
Potential Value $28K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $72,640 firm fixed-price purchase order to Biolytic Lab Performance Inc. for DNA synthesizer maintenance services. The contract, which carries an ultimate completion date of March 25, 2028, supports critical laboratory infrastructure at CDC facilities in Atlanta, Georgia. No set-aside designation was applied to this award. Biolytic Lab Performance Inc., a veteran-owned corporation based in Fremont, California,...
- This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh has awarded a $56,160 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned laboratory equipment specialist based in Fremont, California, for annual maintenance services on DNA synthesizer systems. The contract, awarded on September 30, 2025, with an ultimate completion date of September 29, 2027, covers maintenance and support for the BLP 3900 and BLP Dr. Oligo 48 synthesizer systems. The procurement was...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $56,000 firm fixed-price purchase order to Biolytic Lab Performance Inc. for maintenance services on a DR. OLIGO 48 DNA synthesizer. The contract was awarded on February 10, 2024, with an ultimate completion date of February 9, 2026, and no set-aside designation was used. Biolytic Lab Performance Inc., a veteran-owned corporation headquartered in Fremont, California, specializes in DNA synthesis solutions and advanced...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to CSBIO Instrumentation Co. for the procurement of a CSBIO Fully Automated Peptide Synthesizer. The $58,732.50 contract has an ultimate completion date of August 31, 2024. The synthesizer must have a 20 mL jacketed reaction vessel with automated software-integrated heating and cooling capabilities ranging from -20°C to 90°C, a requirement that the CDC has determined only CSBIO's CS136X model...
- The Centers for Disease Control and Prevention (CDC) awarded a sole source purchase order to CEM Corporation, a for-profit small business and manufacturer of specialized laboratory equipment, for the provision of maintenance and support services for the CEM Liberty Blue Peptide Synthesizer. This $21,735.64 firm fixed-price contract has an ultimate completion date of August 19, 2025. The purchase order was awarded on August 19, 2024 under the authority of FAR 13.106-1(b) and 41 U.S.C. 3304(a)(1),...
- This is a firm fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Life Technologies Corporation, a manufacturer of scientific instruments and reagents, for the purchase of a capillary DNA sequencer. The contract has a potential value of $149,990.00 and a completion date of September 15, 2018. The contract was awarded on August 17, 2018 and does not have a set-aside designation. Life Technologies Corporation has served as a...
- The Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to Life Technologies Corporation for the procurement of two QuantStudio 5Dx Real-Time Polymerase Chain Reaction (PCR) Systems and associated accessories. The contract has a ceiling value of $121,206.26 and a completion date of August 20, 2024. This is a commercial item acquisition conducted under Simplified Acquisition Procedures and is not a set-aside. Life Technologies Corporation is a manufacturer...